top of page

Fund II's first investment

Updated: Jun 12, 2023

Swirltex, headquartered in Calgary, Canada, uses its patented membrane filtration technology to treat difficult wastewater in various applications for potential re-use. 2022 was a pivotal year for Swirltex, with a 10x increase of revenue vs. 2021. 2023 has been very busy, highlighted by the delivery of the ARC Resources treatment system, and the project award of a large US-based customer.

2022 was a banner year for Swirltex, delivering revenues of approximately USD 2.5M. The highlight was the completion and delivery of the ARC Resources treatment system. Final commissioning and full-scale operations will begin in June. Initial operation and water quality data received continues to show the value of the technology.

In the first 5 months of this year Swirltex has added 4 new hires. Engineering added staff to support project management and commissioning efforts, and to capitalize on our success at ARC and another US-based customer, Sales & Marketing also increased their headcount. Furthermore, we are very pleased that Dominik Elsaesser, former CTO of Pentair has joined Swirltex’s board of directors.

The sales funnel is growing with a list of commercial opportunities expected close within the next 12-18 months. A major project in the US has been awarded in early May, adding US $ 1.8 to Swirltex’ book of business. This is Swirltex’ first large-scale US-based project and a jumping-off point into the US market. Project kick-off will be in early June with system delivery expected in Q1/Q2 2024 (exact schedule still TBD). The forecast is for 2023 revenues to be more than 3x 2022 revenue.

Please contact Mazarine if you would like an intro to Swirltex.


bottom of page